These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1670602

  • 21. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K, Abe Y, Horiuchi A, Miyake M, Kimura S.
    Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
    [Abstract] [Full Text] [Related]

  • 22. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY.
    Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674
    [Abstract] [Full Text] [Related]

  • 23. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

  • 24. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J.
    J Immunol; 1993 Mar 01; 150(5):1705-14. PubMed ID: 7679691
    [Abstract] [Full Text] [Related]

  • 25. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA, Kipps TJ.
    Cell Immunol; 1995 Apr 01; 161(2):226-35. PubMed ID: 7535196
    [Abstract] [Full Text] [Related]

  • 26. Influence of various cytokines on the induction of lymphokine-activated killer cells.
    Bergmann L, Weidmann E, Bungert B, Hechler P, Mitrou PS.
    Nat Immun Cell Growth Regul; 1990 Apr 01; 9(4):265-73. PubMed ID: 2120581
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients.
    Provinciali M, Di Stefano G, Stronati S, Fabris N.
    Cytokine; 1998 Feb 01; 10(2):132-9. PubMed ID: 9512903
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
    Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY.
    Cancer Res; 1995 Nov 01; 55(21):4988-94. PubMed ID: 7585540
    [Abstract] [Full Text] [Related]

  • 31. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H, Yssel H, Paliard X, Kastelein R, Figdor C, de Vries JE.
    J Immunol; 1988 Jul 01; 141(1):29-36. PubMed ID: 2454260
    [Abstract] [Full Text] [Related]

  • 32. Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.
    Valentin H, Groux H, Gelin C, Chretien I, Bernard A.
    J Immunol; 1990 Feb 01; 144(3):875-82. PubMed ID: 1967277
    [Abstract] [Full Text] [Related]

  • 33. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD, Economou JS, Shau H, Golub SH.
    J Surg Res; 1993 Nov 01; 55(5):486-92. PubMed ID: 8231167
    [Abstract] [Full Text] [Related]

  • 34. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
    Smyth MJ, Strobl SL, Young HA, Ortaldo JR, Ochoa AC.
    J Immunol; 1991 May 15; 146(10):3289-97. PubMed ID: 1827481
    [Abstract] [Full Text] [Related]

  • 35. Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.
    Yang SC, Owen-Schaub LB, Roth JA, Grimm EA.
    Cancer Res; 1990 Jun 15; 50(12):3526-32. PubMed ID: 2160321
    [Abstract] [Full Text] [Related]

  • 36. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 37. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY.
    J Soc Gynecol Investig; 1995 Feb 15; 2(6):762-71. PubMed ID: 9420887
    [Abstract] [Full Text] [Related]

  • 39. Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes.
    Brooks B, Parry H, Lawry J, Rees R.
    Immunology; 1992 Feb 15; 75(2):343-8. PubMed ID: 1551696
    [Abstract] [Full Text] [Related]

  • 40. Generation of human lymphokine-activated killer cells following brief exposure to high dose interleukin 2.
    Horton SA, Oldham RK, Yannelli JR.
    Cancer Res; 1990 Mar 15; 50(6):1686-92. PubMed ID: 2306722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.